CNMD (Conmed) Total Current Assets : $639 Mil (As of Mar. 2025)

View and export this data going back to 1987. Start your Free Trial

What is Conmed Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Conmed's total current assets for the quarter that ended in Mar. 2025 was $639 Mil.

Conmed Total Current Assets Historical Data

The historical data trend for Conmed's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Total Current Assets Chart

Conmed Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Current Assets

Get a 7-Day Free Trial

416.65

460.12

581.23

615.65

640.01

Conmed Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Current Assets	Get a 7-Day Free Trial															635.72	623.83	641.00	640.01	639.00

Conmed Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Conmed's Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	24.459	+	237.733	+	346.719	+	31.096
	=	640

Conmed's Total Current Assets for the quarter that ended in Mar. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	35.485	+	221.138	+	354.682	+	27.695
	=	639

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Conmed (NYSE:CNMD) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Conmed's Liquidation Value for the quarter that ended in Mar. 2025 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	35.485	-	1320.047	+	0.75 * 221.138	+	0.5 * 354.682
=	-941

Conmed Total Current Assets Related Terms

Thank you for viewing the detailed overview of Conmed's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Conmed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (NYSE:CNMD) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

EC8:Germany

Address

11311 Concept Boulevard, Largo, FL, USA, 33773

Website

https://www.conmed.com

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.

Executives

Charles Farkas	director	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Peters Stanley W Iii	officer: VP GM General Surgery	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
David M Bronson	director
Barbara J Schwarzentraub	director	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Martha Goldberg Aronson	director	40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350
Pat Beyer	officer: President-Conmed International	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Todd W. Garner	officer: Executive Vice President & CFO	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Edward A. Clifford	officer: VP Global Manufacturing	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Curt R Hartman	director	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John D. Ferrell	officer: Executive Vice President - HR	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Brian Concannon	director	HAEMONETICS CORP, 400 WOOD RD, BRAINTREE MA 02184-9144
Daniel Jonas	officer: Vice President/Legal Affairs, other: General Counsel	C/O CONMED CORP, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Terence M Berge	officer: VP Corp. Treasurer	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Peter K Shagory	officer: EVP,STRAT & CORP DEVT	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Johonna Marie Pelletier	officer: Treasurer and VP, Tax	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773